MCP
Mirador Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,626
| Closed | -$3.92M | – | 203 |
|
|
2025
Q1 | $3.92M | Buy |
30,626
+928
| +3% | +$119K | 0.69% | 39 |
|
|
2024
Q4 | $3.93M | Buy |
29,698
+187
| +0.6% | +$24.7K | 0.71% | 36 |
|
|
2024
Q3 | $4.3M | Sell |
29,511
-175
| -0.6% | -$25.5K | 0.77% | 35 |
|
|
2024
Q2 | $4.07M | Buy |
29,686
+853
| +3% | +$117K | 0.77% | 35 |
|
|
2024
Q1 | $3.96M | Buy |
28,833
+860
| +3% | +$118K | 0.76% | 37 |
|
|
2023
Q4 | $3.8M | Sell |
27,973
-4,649
| -14% | -$632K | 0.8% | 33 |
|
|
2023
Q3 | $3.99M | Buy |
32,622
+631
| +2% | +$77.2K | 0.91% | 25 |
|
|
2023
Q2 | $4.06M | Sell |
31,991
-1,476
| -4% | -$187K | 0.96% | 28 |
|
|
2023
Q1 | $4.32M | Sell |
33,467
-2,089
| -6% | -$270K | 1.02% | 28 |
|
|
2022
Q4 | $4.67M | Sell |
35,556
-414
| -1% | -$54.4K | 1.1% | 26 |
|
|
2022
Q3 | $4.21M | Buy |
35,970
+283
| +0.8% | +$33.1K | 1.01% | 24 |
|
|
2022
Q2 | $4.2M | Sell |
35,687
-38
| -0.1% | -$4.47K | 0.99% | 26 |
|
|
2022
Q1 | $4.66M | Buy |
35,725
+1,166
| +3% | +$152K | 0.94% | 27 |
|
|
2021
Q4 | $5.27M | Buy |
34,559
+2,878
| +9% | +$439K | 1.11% | 27 |
|
|
2021
Q3 | $5.12M | Buy |
31,681
+828
| +3% | +$134K | 1.16% | 24 |
|
|
2021
Q2 | $5.05M | Sell |
30,853
-8,049
| -21% | -$1.32M | 1.14% | 27 |
|
|
2021
Q1 | $5.86M | Buy |
38,902
+2,317
| +6% | +$349K | 1.5% | 18 |
|
|
2020
Q4 | $5.54M | Sell |
36,585
-1,081
| -3% | -$164K | 1.52% | 17 |
|
|
2020
Q3 | $5.1M | Buy |
37,666
+1,512
| +4% | +$205K | 1.59% | 17 |
|
|
2020
Q2 | $4.94M | Sell |
36,154
-299
| -0.8% | -$40.9K | 1.85% | 15 |
|
|
2020
Q1 | $4.63M | Buy |
36,453
+3,404
| +10% | +$432K | 1.93% | 16 |
|
|
2019
Q4 | $3.98M | Buy |
+33,049
| New | +$3.98M | 1.61% | 17 |
|
|
2017
Q4 | – | Sell |
-1,225
| Closed | -$415K | – | 145 |
|
|
2017
Q3 | $415K | Sell |
1,225
-6,758
| -85% | -$2.29M | 0.24% | 84 |
|
|
2017
Q2 | $2.52M | Buy |
7,983
+4,576
| +134% | +$1.44M | 1.54% | 18 |
|
|
2017
Q1 | $999K | Buy |
+3,407
| New | +$999K | 0.73% | 47 |
|